NASDAQ · SINT
Healthcare · Medical - Devices
$1.54
Down-$0.24 (-15.58%)
Updated Nov 13, 2026, 8:57 PM
SID Score
3.9/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · SINT
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 12, 2026
SINT closed at $1.54 after 21 trading sessions, down 12.99% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 12, 2026 | $1.60 | $1.605 | $1.53 | $1.54 | 20.19K |
| Nov 11, 2026 | $1.7909 | $1.7909 | $1.51 | $1.62 | 39.17K |
| Nov 10, 2026 | $1.52 | $1.64 | $1.52 | $1.55 | 11.22K |
| Nov 9, 2026 | $1.60 | $1.64 | $1.42 | $1.54 | 41.29K |
| Nov 6, 2026 | $1.64 | $1.64 | $1.55 | $1.56 | 41.03K |
| Nov 5, 2026 | $1.62 | $1.715 | $1.51 | $1.62 | 65.66K |
| Nov 4, 2026 | $1.73 | $1.73 | $1.66 | $1.66 | 56.04K |
| Nov 3, 2026 | $1.72 | $1.795 | $1.70 | $1.72 | 28.09K |
| Nov 2, 2026 | $1.7004 | $1.82 | $1.7004 | $1.71 | 11.86K |
| Oct 30, 2026 | $1.70 | $1.715 | $1.6848 | $1.70 | 4.67K |
| Oct 29, 2026 | $1.71 | $1.74 | $1.71 | $1.72 | 9.47K |
| Oct 28, 2026 | $1.71 | $1.83 | $1.71 | $1.74 | 24.72K |
| Oct 27, 2026 | $1.58 | $1.779 | $1.56 | $1.71 | 33.67K |
| Oct 26, 2026 | $1.56 | $1.66 | $1.5501 | $1.56 | 16.22K |
| Oct 23, 2026 | $1.63 | $1.7163 | $1.58 | $1.58 | 9.6K |
| Oct 22, 2026 | $1.6501 | $1.8199 | $1.64 | $1.64 | 9.01K |
| Oct 21, 2026 | $1.6989 | $1.78 | $1.6989 | $1.74 | 20.2K |
| Oct 20, 2026 | $1.70 | $1.7296 | $1.6672 | $1.72 | 3.5K |
| Oct 19, 2026 | $1.71 | $1.7352 | $1.6592 | $1.70 | 22.26K |
| Oct 16, 2026 | $1.77 | $1.78 | $1.69 | $1.74 | 43.71K |
| Oct 15, 2026 | $1.80 | $1.84 | $1.73 | $1.77 | 15.93K |
The latest Smart Investors Daily articles mentioning SINT.
Company
Market Activity
Research & News
SINT research
Company profile and research snapshot.
SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 1, 2026 | Ascendiant Capital | Buy | — |
| Jun 4, 2026 | Maxim Group | Buy | — |
| May 20, 2026 | HC Wainwright & Co. | Buy | — |
| Apr 13, 2026 | HC Wainwright & Co. | Buy | — |
| Apr 8, 2026 | Ascendiant Capital | Buy | — |
No generated briefing is available yet.
SeekingAlpha · Nov 6, 2026
Sintx Technologies, Inc. (SINT) Q3 2026 Earnings Call November 5, 2026 4:30 PM ESTCompany ParticipantsKevin Ontiveros - Chief Legal OfficerEric Olson - CEO...
Yahoo · Nov 5, 2026
Third quarter revenue increases more than tenfold year over year, while operating losses decrease 51% as Company advances commercialization of its proprietary silicon nitride technologies SALT LAKE CITY, Utah, Nov. 05, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), a global leader in advanced silicon nitride biomaterials and ceramics for medical and industrial applications, today announced its financial results and business highlights for the third q
Benzinga · Nov 5, 2026
SINTX Technologies (NASDAQ:SINT) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga
Yahoo · Oct 22, 2026
SALT LAKE CITY, Utah, Oct. 22, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), a leader in advanced silicon nitride biomaterials and ceramics for medical and industrial applications, today announced that it will release its third quarter 2026 financial results on Thursday, November 5, 2026, after the market close. The Company will also host a conference call and webcast that day at 4:30 p.m. ET to review the Company’s third quarter 2026 performance. M
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning SINT.
